NIKI
Price
$5.70
Change
-$0.57 (-9.09%)
Updated
Sep 11 closing price
Capitalization
4.65M
Intraday BUY SELL Signals
SLGL
Price
$65.94
Change
-$0.85 (-1.27%)
Updated
Sep 11 closing price
Capitalization
215.69M
68 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NIKI vs SLGL

NIKI vs SLGL Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
NIKI vs. SLGL commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NIKI is a StrongBuy and SLGL is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLGL($216M) has a higher market cap than NIKI($4.65M). SLGL YTD gains are higher at: 56.478 vs. NIKI (-46.226). NIKI has higher annual earnings (EBITDA): -1.82M vs. SLGL (-17.64M). SLGL has more cash in the bank: 47.9M vs. NIKI (3.45M). SLGL has less debt than NIKI: SLGL (770K) vs NIKI (3.44M). SLGL has higher revenues than NIKI: SLGL (1.8M) vs NIKI (0).
NIKISLGLNIKI / SLGL
Capitalization4.65M216M2%
EBITDA-1.82M-17.64M10%
Gain YTD-46.22656.478-82%
P/E RatioN/AN/A-
Revenue01.8M-
Total Cash3.45M47.9M7%
Total Debt3.44M770K447%
FUNDAMENTALS RATINGS
NIKI vs SLGL: Fundamental Ratings
NIKI
SLGL
OUTLOOK RATING
1..100
5066
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
75
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9397
PRICE GROWTH RATING
1..100
8743
P/E GROWTH RATING
1..100
2197
SEASONALITY SCORE
1..100
9018

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NIKI's Valuation (44) in the Pharmaceuticals Major industry is in the same range as SLGL (75). This means that NIKI’s stock grew similarly to SLGL’s over the last 12 months.

NIKI's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as SLGL (100). This means that NIKI’s stock grew similarly to SLGL’s over the last 12 months.

NIKI's SMR Rating (93) in the Pharmaceuticals Major industry is in the same range as SLGL (97). This means that NIKI’s stock grew similarly to SLGL’s over the last 12 months.

SLGL's Price Growth Rating (43) in the Pharmaceuticals Major industry is somewhat better than the same rating for NIKI (87). This means that SLGL’s stock grew somewhat faster than NIKI’s over the last 12 months.

NIKI's P/E Growth Rating (21) in the Pharmaceuticals Major industry is significantly better than the same rating for SLGL (97). This means that NIKI’s stock grew significantly faster than SLGL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NIKISLGL
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 23 days ago
81%
Bullish Trend 11 days ago
79%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (NIKI: $5.70 vs. SLGL: $65.94)
Brand notoriety: NIKI and SLGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NIKI: 20% vs. SLGL: 47%
Market capitalization -- NIKI: $4.65M vs. SLGL: $215.69M
NIKI [@Biotechnology] is valued at $4.65M. SLGL’s [@Biotechnology] market capitalization is $215.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NIKI’s FA Score shows that 1 FA rating(s) are green while SLGL’s FA Score has 0 green FA rating(s).

  • NIKI’s FA Score: 1 green, 4 red.
  • SLGL’s FA Score: 0 green, 5 red.
According to our system of comparison, NIKI is a better buy in the long-term than SLGL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NIKI’s TA Score shows that 3 TA indicator(s) are bullish while SLGL’s TA Score has 4 bullish TA indicator(s).

  • NIKI’s TA Score: 3 bullish, 4 bearish.
  • SLGL’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, NIKI is a better buy in the short-term than SLGL.

Price Growth

NIKI (@Biotechnology) experienced а -8.06% price change this week, while SLGL (@Biotechnology) price change was -5.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

SLGL is expected to report earnings on Nov 19, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
NIKI
Daily Signal:
Gain/Loss:
SLGL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MSGY2.080.21
+11.23%
Masonglory Limited
SBAC185.474.05
+2.23%
SBA Communications Corp
PHR10.310.14
+1.38%
Phreesia
CPK129.820.23
+0.18%
Chesapeake Utilities
PUSA3.66-0.01
-0.27%
Aureus Greenway Holdings Inc.

NIKI and

Correlation & Price change

A.I.dvisor indicates that over the last year, NIKI has been loosely correlated with CANF. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if NIKI jumps, then CANF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NIKI
1D Price
Change %
NIKI100%
-9.09%
CANF - NIKI
48%
Loosely correlated
+7.87%
APVO - NIKI
46%
Loosely correlated
+0.55%
ICU - NIKI
45%
Loosely correlated
-3.51%
MLEC - NIKI
45%
Loosely correlated
-5.00%
GNPX - NIKI
44%
Loosely correlated
N/A
More

SLGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLGL has been loosely correlated with TRAW. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SLGL jumps, then TRAW could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLGL
1D Price
Change %
SLGL100%
-1.27%
TRAW - SLGL
48%
Loosely correlated
+6.17%
NEUP - SLGL
36%
Loosely correlated
-0.80%
NIKI - SLGL
34%
Loosely correlated
-9.09%
GTBP - SLGL
33%
Poorly correlated
+39.32%
AVXL - SLGL
31%
Poorly correlated
-1.50%
More